Young Investigator Poster Awards
November 7, 2025
Presented below are the winners of the 2025 NEI Fall Congress Young...
Read More
FDA Approves Lumateperone as Adjunctive Treatment for Major Depressive Disorder
November 6, 2025
The FDA has approved lumateperone as an adjunctive therapy with an...
Read More
Child and Adolescent Psychiatry Academy
November 5, 2025
The 2025 NEI Child and Adolescent Psychiatry Academy presented a se...
Read More
GLP-1 Receptor Agonists for the Treatment of Opioid Use Disorders
October 14, 2025
Opioid Use Disorder (OUD) remains a major public health crisis, wit...
Read More
Lurasidone Efficacious for Depression Across Psychiatric Diagnoses
October 10, 2025
Depressive symptoms are a key driver of morbidity across multiple p...
Read More
Advancing ADHD Awareness Through Evidence-Based Practice
October 8, 2025
October is ADHD Awareness Month. The goal of ADHD Awareness Month i...
Read More
Chronic Insomnia Associated with Elevated Risk of Cognitive Decline
October 5, 2025
Chronic insomnia is prevalent in older adults, affecting up to 70%,...
Read More
APA Issues Guideline on Delirium Prevention and Treatment
October 2, 2025
The American Psychiatric Association (APA) recently released update...
Read More
Lithium Deficiency and Alzheimer’s Disease: A Potential Modifiable Risk Factor
September 26, 2025
Recent research published in Nature has identified endogenous lithi...
Read More
SSRIs and SNRIs Lower Relapse in Clozapine Treated Schizophrenia
September 23, 2025
Clozapine remains the gold standard for treatment-resistant schizop...
Read More
Prolonged Exposure Therapy Effective Across Trauma Types and Populations
September 15, 2025
There are many studies that examine the impact of post-traumatic st...
Read More
Hearing Loss, Hearing Aid Use, and Neuropsychiatric Symptoms among Persons Living with Dementia
September 8, 2025
Neuropsychiatric symptoms such as depression, apathy, and agitation...
Read More